Zusammenfassung
Neueren Erkenntnissen nach sind Karzinosarkome epithelialen Ursprungs. Sie werden dennoch aus Gründen der besseren Übersichtlichkeit und zu deren besserer Abgrenzung nicht unter den anderen epithelialen Malignomen des Uterus, sondern eigens in diesem Kapitel behandelt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amant F, Cadron I, Fuso L et al. (2005) Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial epithelial endometrial cancer. Gynecol Oncol 98: 274–280
Arend R, Herzog T, Sun X et al. (2010) Long-term outcome and natural history of uterine adenosarcomas. Gynecol Oncol 116: S92 (Abstr. 232)
Bansal N, Herzog T, Hershman D et al. (2008) Uterine carcinosarcomas versus grade 3 endometrioid cancers: The debate revisited. Gynecol Oncol 108: p145
Brooks SE, Zhan M, Cote T, Baquet CR (2004) Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol 93: 204–208
Chi DS, Mychalczak B, Saigo PE, Rescigno J, Brown CL (1997) The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol Oncol 65: 493–498
Clement PB, Scully RE (1990) Müllerian adenosarcoma of the uterus: a clinicopathologic study of 100 cases with a review of the literature. Hum Pathol 21: 363–381
Dinh TV, Slavin RE, Bhagavan BS, Hannigan EV, Tiamson EM, Yandell RB (1989) Mixed mullerian tumors of the uterus: a clinicopathologic study. Obstet Gynecol 74: 388–392
Evans MJ, Langlois NE, Kitchener HC, Miller ID (1995) Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Mullerian tumor) of the uterus? Int J Gynecol Cancer 4: 310–313
Garg G, Shah J, Kumar S et al. (2010) Ovarian and uterine carcinosarcomas. Int J Gynaecol Cancer 20: 888–894
Gerszten K, Faul C, Kounelis S, Huang Q, Kelley J, Jones MW (1998) The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol 68: 8–13
Hendrickson MR, Tavassoli FA, Kempson RL, McCluggage WG, Haller U, Kubik-Huch RA (2003) Mesenchymal tumours and related lesions. In: Tavassoli FA, Devilee P (eds.) Tumours of the Breast and female genital organs. IARC Press, Lyon, pp. 233–244
Homesley H, Filiaci V, Markman M et al. (2007) Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group study. J Clin Oncol 25: 526–531
Kaku T, Silverberg SG, Major FJ, Miller A, Fetter B, Brady MF (1992) Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11: 75–88
Manolitsas TP, Wain GV, Williams KE, Freidlander M, Hacker NF (2001) Multimodality therapy for patients with clinical stage I and II malignant mixed Müllerian tumors of the uterus. Cancer 91: 1437–1443
Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, Yordan E, Brady MF (1993) Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71: 1702–1709
Mc Cluggage WG, Haller U, Kurman RJ, Kubik-Huch RA (2003) Mixed epithelial and mesenchymal tumours. In: Tavassoli FA, Devilee P (eds.) Tumours of the Breast and female genital organs. IARC Press, Lyon, pp. 245–249
Muss HB, Bundy BN, DISaia PJ, Homesley HD, Fowler WC, Creasman W, Yordan E (1985) Treatment of recurrent or advanced uterine sarcoma: a randomized trial of doxorubicin versus doxorubicin and cyclophosphamide: a phase III trial of the Gynecologic Oncology Group. Cancer 55: 1648–1653
Nemani D, Mitra N, Guo M et al. (2008) Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis. Gynecol Oncol 111: 82–88
Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, Zaino RT (1983) A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52: 626–632
Reed NS, Mangioni C, Malmstrom H et al. (2008) Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an EORTC Gynaecological Cancer Group study (protocol 55874). Eur J Cancer 44: 808–818
Sreenan JJ, Hart WR (1995) Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 19: 666–674
Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY et al. (1990) Carcinosarcoma (malignant mixed medodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9: 1–19
Sutton GP, Blessing JA, Carson LF, Lentz SS, Whitney CW, Gallion HH (1997) Adjuvant ifosfamide, mesna, and cisplatin in patients with completely resected stage I or II carcinosarcoma of the uterus: a Gynecologic Oncology Group study. Proc ASCO 16: 362a
Sutton G, Brunetto VL, Kilgore L et al. (2000) A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A gynecologic oncology group study. Gynecol Oncol 79: 147–1453
Sutton G, Kauderer J, Carson LF, Lentz SS, Whitney CW, Gallion H (2005) Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 96: 630–634
Wolfson AH, Brady MF, Rocereto T et al. (2007) A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol 107: 177–185
Yamada SD, Burger RA, Brewster WR, Anton D, Kohler MF, Monk BJ (2000) Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer 88: 2782–2786
Zaloudek CJ, Norris HJ (1981) Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases. Cancer 48: 354–366
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fehr, M.K., Fink, D. (2011). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, E., Jonat, W., Fink, D., Köchli, O. (eds) Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17076-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-17076-8_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-17075-1
Online ISBN: 978-3-642-17076-8
eBook Packages: Medicine (German Language)